Modulation of amyloid‐β‐induced and age‐associated changes in rat hippocampus by eicosapentaenoic acid
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
The age‐related deficit in long‐term potentiation (LTP) in the dentate gyrus is positively correlated with hippocampal concentration of the pro‐inflammatory cytokine, interleukin‐1β (IL‐1β). Previous evidence also indicates that the inhibition of LTP induced by intracerebroventricular injection of amyloid‐β 1–40 (Aβ) is accompanied by increased hippocampal IL‐1β concentration and IL‐1β‐stimulated signalling, specifically activation of the stress‐activated protein kinase, c‐jun N‐terminal kinase (JNK). We considered that the underlying age‐related neuroinflammation may render older rats more susceptible to Aβ administration and, to investigate this, young, middle‐aged and aged rats were injected intracerebroventricularly with Aβ or vehicle. Hippocampal IL‐1β concentration, JNK phosphorylation, expression of the putative Aβ receptor, Receptor for advanced glycation end products (RAGE) and the microglial cell surface marker, CD40 were assessed. We report that Aβ inhibited LTP in a concentration‐dependent manner in young rats and that this was accompanied by concentration‐dependent increases in hippocampal IL‐1β and expression of phosphorylated JNK, RAGE and CD40. While 20 μmol/L Aβ exerted no significant effect on LTP in young rats, it inhibited LTP in middle‐aged and aged rats and the increased vulnerability of aged rats was associated with increased IL‐1β concentration. Treatment of rats with eicosapentaenoic acid attenuated the inhibitory effect of 60 μmol/L Aβ on LTP in young rats and the effect of 20 μmol/L Aβ in middle‐aged and aged rats. We present evidence which indicates that the effect of eicosapentaenoic acid may be linked with its ability to stimulate activation of peroxisome proliferator‐activated receptor gamma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The mechanisms of action of PPARs
Berger, J., & Moller, D. E. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104018 · Cited by 2,659
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777
Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
Block, M. L., & Hong, J.-S. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.004 · Cited by 1,557
Godbout, J. P., Chen, J., Abraham, J., Richwine, A. F., Berg, B. M., Kelley, K. W., & Johnson, R. W. (2005) · The FASEB Journal · doi:10.1096/fj.05-3776fje · Cited by 813
Blum-Degena, D., Müller, T., Kuhn, W., Gerlach, M., Przuntek, H., & Riederer, P. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12192-7 · Cited by 801
Polyunsaturated fatty acids, inflammation, and immunity
Calder, P. C. (2001) · Lipids · doi:10.1007/s11745-001-0812-7 · Cited by 784
Li, Y., Liu, L., Barger, S. W., & Griffin, W. S. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-05-01605.2003 · Cited by 563
Wang, H.-W., Pasternak, J. F., Kuo, H., Ristic, H., Lambert, M. P., Chromy, B., Viola, K. L., Klein, W. L., Stine, W. B., Krafft, G. A., et al. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03058-x · Cited by 527 · cited 1×
“…other reports which indicated that various Ab peptide fragments (Freir et al. 2001) as well as naturally-secreted oligomers (Walsh et al. 2002) exerted an inhibitory effect on LTP, while Ab has been shown to inhibit LTP in vitro (Chen et al. 2000; Saleshando and O’Connor 2000; Wang et al. 2002).”
BackgroundA neuromodulatory role of interleukin-1β in the hippocampus
Schneider, H., Pitossi, F., Balschun, D., Wagner, A., del Rey, A., & Besedovsky, H. O. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7778 · Cited by 498
Lue, L.-F., Walker, D. G., Brachova, L., Beach, T. G., Rogers, J., Schmidt, A. M., Stern, D. M., & Yan, S. D. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7732 · Cited by 439
Cited by
Polyunsaturated fatty acids and their metabolites in brain function and disease
Bazinet, R. P., & Layé, S. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3820 · Cited by 1,605
Dyall, S. C. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00052 · Cited by 943
Neuronal Lipid Metabolism: Multiple Pathways Driving Functional Outcomes in Health and Disease
Tracey, T. J., Steyn, F. J., Wolvetang, E. J., & Ngo, S. T. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00010 · Cited by 433
Luchtman, D. W., & Song, C. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.019 · Cited by 319
NLRP3 inflammasome activation in inflammaging
Latz, E., & Duewell, P. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.09.001 · Cited by 174
Metadata
- Authors
- Minogue, A. M., Lynch, A. M., Loane, D. J., Herron, C. E., & Lynch, M. A.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2007-07-17
- Volume
- 103
- Issue
- 3
- Pages
- 914-926
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2139781256
- Cited by
- 96
- References
- 16
- FWCI
- 3.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Modulation of amyloid‐β‐induced and age‐associated changes in rat hippocampus by eicosapentaenoic acid. https://app.cochat.ai/papers/10.1111/j.1471-4159.2007.04848.x
- The paper
- Minogue, A. M., Lynch, A. M., Loane, D. J., Herron, C. E., & Lynch, M. A. (2007). Modulation of amyloid‐β‐induced and age‐associated changes in rat hippocampus by eicosapentaenoic acid. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2007.04848.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.